Efavirenz pharmacokinetics during pregnancy and infant washout

BACKGROUND: Limited data exist on efavirenz pharmacokinetics in HIV-positive pregnant women and neonatal washout. METHODS: HIV-infected pregnant women receiving 600 mg efavirenz once daily had intensive steady-state 24-hour pharmacokinetics profiles during the second trimester (2T), third trimester...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antivir Ther
Auteurs principaux: Kreitchmann, Regis, Schalkwijk, Stein, Best, Brookie, Wang, Jiajia, Colbers, Angela, Stek, Alice, Shapiro, David, Cressey, Tim, Mirochnick, Mark, Burger, David
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6642905/
https://ncbi.nlm.nih.gov/pubmed/30530925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3283
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires